APA

Mau-Sørensen M., Dittrich C., Dienstmann R., Lassen U., Büchler W., Martinius H. & Tabernero J. (20150807). A phase I trial of intravenous catumaxomab: a bispecific monoclonal antibody targeting EpCAM and the T cell coreceptor CD3. : Cancer chemotherapy and pharmacology.

Chicago

Mau-Sørensen Morten, Dittrich Christian, Dienstmann Rodrigo, Lassen Ulrik, Büchler Wilfried, Martinius Holger and Tabernero Josep. 20150807. A phase I trial of intravenous catumaxomab: a bispecific monoclonal antibody targeting EpCAM and the T cell coreceptor CD3. : Cancer chemotherapy and pharmacology.

Harvard

Mau-Sørensen M., Dittrich C., Dienstmann R., Lassen U., Büchler W., Martinius H. and Tabernero J. (20150807). A phase I trial of intravenous catumaxomab: a bispecific monoclonal antibody targeting EpCAM and the T cell coreceptor CD3. : Cancer chemotherapy and pharmacology.

MLA

Mau-Sørensen Morten, Dittrich Christian, Dienstmann Rodrigo, Lassen Ulrik, Büchler Wilfried, Martinius Holger and Tabernero Josep. A phase I trial of intravenous catumaxomab: a bispecific monoclonal antibody targeting EpCAM and the T cell coreceptor CD3. : Cancer chemotherapy and pharmacology. 20150807.